High growth, Lower R & D-Low is a long-term gamble or risk purchase?
Offering for sale (of), price between ₹540 and ₹570 per share as an important point for companies, which have shown income growth, international growth, and a profit in the past three years. Over 8,000 medicinal development projects across 44 countries,…

